Germline PAX5 mutations and B cell leukemia

被引:0
作者
R Katherine Hyde
P Paul Liu
机构
[1] Genetics and Molecular Biology Branch,
[2] National Human Genome Research Institute,undefined
[3] US National Institutes of Health,undefined
来源
Nature Genetics | 2013年 / 45卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The transcription factor PAX5 is required for normal B cell development and is frequently mutated or deleted in B cell precursor acute lymphoblastic leukemia (B-ALL). A new study demonstrates that germline hypomorphic mutations of PAX5 are associated with susceptibility to B-ALL, implicating PAX5 in a growing list of hematopoietic transcription factors mutated in familial leukemia predisposition syndromes.
引用
收藏
页码:1104 / 1105
页数:1
相关论文
共 50 条
[21]   Transcriptional control of B cell identity by Pax5 [J].
Cobaleda, C ;
Delogu, A ;
Schebesta, A ;
Busslinger, M .
IMMUNOLOGY, 2005, 116 :30-31
[22]   Clinical and immunophenotypic characteristics of familial leukemia predisposition caused by PAX5 germline variants [J].
Adela Escudero ;
Masatoshi Takagi ;
Franziska Auer ;
Ulrike Anne Friedrich ;
Satoshi Miyamoto ;
Atsushi Ogawa ;
Kohsuke Imai ;
Barbara Pascual ;
María Vela ;
Polina Stepensky ;
Layal Yasin ;
Sarah Elitzur ;
Arndt Borkhardt ;
Antonio Pérez-Martínez ;
Julia Hauer .
Leukemia, 2022, 36 :2338-2342
[23]   Pax5: the guardian of B cell identity and function [J].
Cobaleda, Cesar ;
Schebesta, Alexandra ;
Delogu, Alessio ;
Busslinger, Meinrad .
NATURE IMMUNOLOGY, 2007, 8 (05) :463-470
[24]   Pax5: the guardian of B cell identity and function [J].
César Cobaleda ;
Alexandra Schebesta ;
Alessio Delogu ;
Meinrad Busslinger .
Nature Immunology, 2007, 8 :463-470
[25]   A Novel Germline PAX5 Single Exon Deletion in a Paediatric Patient with B-Cell Leukaemia [J].
van Engelen, Nienke ;
Roest, Merel A. ;
van Dijk, Freerk ;
Sonneveld, Edwin ;
Bladergroen, Reno ;
van Reijmersdal, Simon ;
van der Velden, Vincent H. J. ;
Hoogeveen, Patricia G. ;
Kors, W. A. ;
Waanders, Esme ;
Kuiper, Roland P. ;
Jongmans, Marjolijn C. J. .
BLOOD, 2022, 140 :3181-3181
[26]   PAX5 FUSIONS ARE RECURRENT AND ASSOCIATED TO POOR OUTCOME IN MLL-GERMLINE INFANT B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA [J].
Fazio, G. ;
Grioni, A. ;
De Lorenzo, P. ;
Quadri, M. ;
Pedace, L. ;
Corral, L. ;
Palamini, S. ;
Bardini, M. ;
Buldini, B. ;
Locatelli, F. ;
Valsecchi, M. G. ;
Biondi, A. ;
Cazzaniga, G. .
HAEMATOLOGICA, 2020, 105 :S47-S48
[27]   Pax5 isoform expression and mutation status in B-cell chronic lymphocytic leukemia [J].
Arseneau, Jean-Rene ;
Laflamme, Mark ;
Ouellette, Rodney .
FASEB JOURNAL, 2008, 22
[28]   ROLE OF PAX5 FUSION PROTEINS IN B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA [J].
Smeenk, Leonie ;
Werner, Barbara ;
Azaryan, Anna ;
Busslinger, Meinrad .
EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) :S46-S46
[29]   Alternative splicing of the trout Pax5 gene and identification of novel B cell populations using Pax5 signatures [J].
MacMurray, Elizabeth ;
Barr, Maggie ;
Bruce, Amber ;
Epp, Lidia ;
Zwollo, Patty .
DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY, 2013, 41 (02) :270-281
[30]   B-cell commitment: Pax5 is the deciding factor [J].
Enver, T .
CURRENT BIOLOGY, 1999, 9 (24) :R933-R935